{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:59:15Z","timestamp":1792198755885,"version":"4.4.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","jada.ada.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of the American Dental Association"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.adaj.2015.07.020","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T08:45:21Z","timestamp":1446799521000},"page":"98-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Short-term use of nonsteroidal anti-inflammatory drugs and adverse effects"],"prefix":"10.1016","volume":"147","author":[{"given":"Anita","family":"Aminoshariae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Kulild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Donaldson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adaj.2015.07.020_bib1","unstructured":"US Food and Drug Administration. FDA strengthens warning of heart attack and stroke risk for non-steroidal anti-inflammatory drugs. Available at: http:\/\/www.fda.gov\/ForConsumers\/ConsumerUpdates\/ucm453610.htm. Accessed July 20,\u00a02015."},{"issue":"4","key":"10.1016\/j.adaj.2015.07.020_bib2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0091-6749(84)90115-5","article-title":"Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs","volume":"74","author":"Stevenson","year":"1984","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.adaj.2015.07.020_bib3","unstructured":"US Food and Drug Administration. Medication guide for non-steroidal anti-inflammatory drugs (NSAIDs). Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM191085.pdf. Accessed June 11,\u00a02015."},{"issue":"20","key":"10.1016\/j.adaj.2015.07.020_bib4","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jacc.2008.08.041","article-title":"Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population","volume":"52","author":"Garc\u00eda Rodr\u00edguez","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.adaj.2015.07.020_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.amjmed.2013.08.017","article-title":"NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease","volume":"127","author":"Kohli","year":"2014","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.adaj.2015.07.020_bib6","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.amjcard.2009.01.014","article-title":"An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs","volume":"103","author":"Farkouh","year":"2009","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.adaj.2015.07.020_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1741-7015-3-17","article-title":"Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population","volume":"3","author":"Garcia Rodr\u00edguez","year":"2005","journal-title":"BMC Med"},{"issue":"5","key":"10.1016\/j.adaj.2015.07.020_bib8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/oxfordjournals.aje.a010234","article-title":"Nonsteroidal antiinflammatory drugs\u00a0and acute renal failure in elderly persons","volume":"151","author":"Griffin","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.adaj.2015.07.020_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-115-3-165","article-title":"Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease","volume":"115","author":"Sandler","year":"1991","journal-title":"Ann Intern Med"},{"issue":"25","key":"10.1016\/j.adaj.2015.07.020_bib10","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJM199412223312502","article-title":"Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs","volume":"331","author":"Perneger","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.adaj.2015.07.020_bib11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/pds.3227","article-title":"Use of nonsteroidal anti-inflammatory drugs prior to chronic renal replacement therapy initiation: a nationwide study","volume":"21","author":"Kristensen","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.adaj.2015.07.020_bib12","first-page":"43","article-title":"Epidemiology overview of gastrointestinal and renal toxicity of NSAIDs","volume":"135","author":"Henry","year":"2003","journal-title":"Int J Clin Prac Suppl"},{"issue":"1","key":"10.1016\/j.adaj.2015.07.020_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-230X-9-41","article-title":"Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use","volume":"9","author":"Straube","year":"2009","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"10.1016\/j.adaj.2015.07.020_bib14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/apt.12174","article-title":"Comparison of gastroduodenal ulcer incidence in healthy Japanese subjects taking celecoxib or loxoprofen evaluated by endoscopy: a placebo-controlled, double-blind 2-week study","volume":"37","author":"Sakamoto","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.adaj.2015.07.020_bib15","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0091-6749(96)70123-9","article-title":"Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes","volume":"98","author":"Stevenson","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.adaj.2015.07.020_bib16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.adaj.2015.07.020_bib17","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1468-2982.2005.00948.x","volume":"25","author":"Diener","year":"2005","journal-title":"Cephalalgia"},{"issue":"12","key":"10.1016\/j.adaj.2015.07.020_bib18","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/gut.2005.080754","article-title":"Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations","volume":"55","author":"Lanas","year":"2006","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.adaj.2015.07.020_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejphar.2013.09.032","article-title":"Drug\/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets","volume":"721","author":"Saxena","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.adaj.2015.07.020_bib20","unstructured":"Lexicomp. Lexicomp online for dentistry. Available at: http:\/\/webstore.lexi.com\/ONLINE-Software-for-Dentists. Accessed June 6,\u00a02015."},{"issue":"2","key":"10.1016\/j.adaj.2015.07.020_bib21","first-page":"MR000010","article-title":"Grey literature in meta-analyses of randomized trials of health care interventions","author":"Hopewell","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.adaj.2015.07.020_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews","volume":"7","author":"Shea","year":"2007","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"10.1016\/j.adaj.2015.07.020_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-0528.2010.00584.x","article-title":"An appraisal of the quality of published qualitative dental research","volume":"39","author":"Masood","year":"2011","journal-title":"Community Dent Oral Epidemiol"},{"issue":"7650","key":"10.1016\/j.adaj.2015.07.020_bib24","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.adaj.2015.07.020_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archinte.165.2.161","article-title":"The effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus","volume":"165","author":"Sowers","year":"2005","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.adaj.2015.07.020_bib26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00228-012-1370-y","article-title":"Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: a placebo-controlled, ex\u00a0vivo, serial placebo-controlled serial crossover study","volume":"69","author":"Meek","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.adaj.2015.07.020_bib27","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjcard.2007.11.054","article-title":"The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers","volume":"101","author":"Gladding","year":"2008","journal-title":"Am J Cardiol"},{"issue":"25","key":"10.1016\/j.adaj.2015.07.020_bib28","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.adaj.2015.07.020_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clinthera.2005.01.011","article-title":"Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers","volume":"27","author":"Cryer","year":"2005","journal-title":"Clin Ther"},{"issue":"8","key":"10.1016\/j.adaj.2015.07.020_bib30","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/jama.2015.0809","article-title":"Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction","volume":"313","author":"Olsen","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.adaj.2015.07.020_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00045391-200103000-00003","article-title":"Cyclooxygenase-2\u2013specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients","volume":"8","author":"Whelton","year":"2001","journal-title":"Am J Ther"},{"issue":"7","key":"10.1016\/j.adaj.2015.07.020_bib32","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/hrt.2010.200717","article-title":"Effect of short-term NSAID use on echocardiographic parameters in elderly people: a population-based cohort study","volume":"97","author":"van den Hondel","year":"2011","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.adaj.2015.07.020_bib33","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1177\/0091270002042009005","article-title":"Effects of celecoxib and diclofenac on blood pressure, renal function, and vasoactive prostanoids in young and elderly subjects","volume":"42","author":"Dilger","year":"2002","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.adaj.2015.07.020_bib34","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/CIRCULATIONAHA.105.595793","article-title":"Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events","volume":"113","author":"Chan","year":"2006","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.adaj.2015.07.020_bib35","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2165\/00002018-200225070-00007","article-title":"Renal failure associated with the use of celecoxib and rofecoxib","volume":"25","author":"Ahmad","year":"2002","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.adaj.2015.07.020_bib36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1067\/mcp.2002.126182","article-title":"Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet","volume":"72","author":"Schwartz","year":"2002","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.adaj.2015.07.020_bib37","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/jjco\/hys145","article-title":"Short-term administration of diclofenac sodium affects renal function after laparoscopic radical nephrectomy in elderly patients","volume":"42","author":"Mizuno","year":"2012","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"10.1016\/j.adaj.2015.07.020_bib38","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/hep.20595","article-title":"Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites","volume":"41","author":"Cl\u00e0ria","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.adaj.2015.07.020_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00228-002-0440-y","article-title":"Effects of short-term treatment with diclofenac-colestyramine on renal function and urinary prostanoid excretion in patients with type-2 diabetes","volume":"58","author":"Farker","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.adaj.2015.07.020_bib40","first-page":"301","article-title":"Gastrointestinal tolerability of ibuprofen compared with paracetamol and aspirin at over-the-counter doses","volume":"30","author":"Rampal","year":"2002","journal-title":"J\u00a0Int Med Res"},{"issue":"10","key":"10.1016\/j.adaj.2015.07.020_bib41","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1742-1241.2002.tb11366.x","article-title":"Tolerability of ibuprofen, aspirin and paracetamol for the treatment of cold and flu symptoms and sore throat pain","volume":"56","author":"Moore","year":"2002","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1016\/j.adaj.2015.07.020_bib42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s100670200007","article-title":"Comparative tolerability of paracetamol, aspirin and ibuprofen for short-term analgesia in patients with musculoskeletal conditions: results in 4291 patients","volume":"21","author":"Le Parc","year":"2002","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.adaj.2015.07.020_bib43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/pds.1083","article-title":"A\u00a0large simple clinical trial prototype for assessment of OTC drug effects using patient-reported data","volume":"14","author":"Van Ganse","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"10.1016\/j.adaj.2015.07.020_bib44","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/j.1365-2036.2006.02912.x","article-title":"The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor","volume":"23","author":"Goldstein","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.adaj.2015.07.020_bib45","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.gie.2008.08.017","article-title":"Prevention of nonsteroidal anti-inflammatory drug\u2013induced small-intestinal injury by prostaglandin: a\u00a0pilot randomized controlled trial evaluated by capsule endoscopy","volume":"69","author":"Fujimori","year":"2009","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"10.1016\/j.adaj.2015.07.020_bib46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2710.2008.00989.x","article-title":"Gastrointestinal tolerability of aspirin and the choice of over-the-counter analgesia for short-lasting acute pain","volume":"34","author":"Steiner","year":"2009","journal-title":"J\u00a0Clin Pharm Ther"},{"issue":"3","key":"10.1016\/j.adaj.2015.07.020_bib47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/11593880-000000000-00000","article-title":"Short-term acetylsalicylic acid (aspirin) use for pain, fever, or colds: gastrointestinal adverse effects","volume":"11","author":"Lanas","year":"2011","journal-title":"Drugs R D"},{"issue":"3","key":"10.1016\/j.adaj.2015.07.020_bib48","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bdj.4809898","article-title":"An investigation into the comparative efficacy of soluble aspirin and solid paracetamol in postoperative pain after third molar surgery","volume":"194","author":"Seymour","year":"2003","journal-title":"Br Dent J"},{"issue":"3","key":"10.1016\/j.adaj.2015.07.020_bib49","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1053\/gast.2003.50096","article-title":"Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study","volume":"124","author":"Fiorucci","year":"2003","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.adaj.2015.07.020_bib50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40268-013-0011-y","article-title":"Gastrointestinal adverse effects of short-term aspirin use: a meta-analysis of published randomized controlled trials","volume":"13","author":"Baron","year":"2013","journal-title":"Drugs R D"},{"issue":"12","key":"10.1016\/j.adaj.2015.07.020_bib51","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1136\/thx.2008.101196","article-title":"Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma","volume":"63","author":"Gaber","year":"2008","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.adaj.2015.07.020_bib52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1081\/JAS-120026063","article-title":"Safety of selective COX-2 inhibitors in aspirin\/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib","volume":"41","author":"Bavbek","year":"2004","journal-title":"J\u00a0Asthma"},{"issue":"1","key":"10.1016\/j.adaj.2015.07.020_bib53","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000096000","article-title":"Safety of meloxicam in aspirin-hypersensitive patients with asthma and\/or nasal polyps","volume":"142","author":"Bavbek","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"10.1016\/j.adaj.2015.07.020_bib54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1081-1206(10)61378-6","article-title":"Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease","volume":"97","author":"El Miedany","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.adaj.2015.07.020_bib55","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1067\/mai.2003.1450","article-title":"Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib","volume":"111","author":"Gyllfors","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.adaj.2015.07.020_bib56","first-page":"20","article-title":"Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients","volume":"13","author":"Martin-Garcia","year":"2003","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"6","key":"10.1016\/j.adaj.2015.07.020_bib57","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1378\/chest.121.6.1812","article-title":"Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma","volume":"121","author":"Martin-Garcia","year":"2002","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.adaj.2015.07.020_bib58","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jaci.2006.12.616","article-title":"Tolerability to nabumetone and meloxicam in patients with nonsteroidal anti-inflammatory drug intolerance","volume":"119","author":"Prieto","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.adaj.2015.07.020_bib59","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/art.10426","article-title":"The safety of celecoxib in patients with aspirin-sensitive asthma","volume":"46","author":"Woessner","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.adaj.2015.07.020_bib60","unstructured":"Center for Evidence-Based Medicine. OCEBM levels of evidence. Available at: http:\/\/www.cebm.net\/index.aspx?o=5653. Accessed September 4, 2015."},{"key":"10.1016\/j.adaj.2015.07.020_bib61","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.adaj.2015.07.020_bib62","doi-asserted-by":"crossref","first-page":"690","DOI":"10.7326\/M13-1581","article-title":"Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study","volume":"161","author":"Lamberts","year":"2014","journal-title":"Ann Intern Med"},{"issue":"13","key":"10.1016\/j.adaj.2015.07.020_bib63","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.296.13.jrv60011","article-title":"Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2","volume":"296","author":"McGettigan","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.adaj.2015.07.020_bib64","doi-asserted-by":"crossref","first-page":"e1001388","DOI":"10.1371\/journal.pmed.1001388","article-title":"Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries","volume":"10","author":"McGettigan","year":"2013","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.adaj.2015.07.020_bib65","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1742-7843.2006.pto_302.x","article-title":"Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction","volume":"98","author":"Hern\u00e1ndez-D\u00edaz","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"9","key":"10.1016\/j.adaj.2015.07.020_bib66","doi-asserted-by":"crossref","first-page":"e1001098","DOI":"10.1371\/journal.pmed.1001098","article-title":"Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies","volume":"8","author":"McGettigan","year":"2011","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.adaj.2015.07.020_bib67","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.EDE.0000034633.74133.C3","article-title":"Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure","volume":"14","author":"Garc\u00eda Rodr\u00edguez","year":"2003","journal-title":"Epidemiology"},{"issue":"11","key":"10.1016\/j.adaj.2015.07.020_bib68","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1136\/hrt.2005.082388","article-title":"Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population","volume":"92","author":"Huerta","year":"2006","journal-title":"Heart"},{"issue":"12","key":"10.1016\/j.adaj.2015.07.020_bib69","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1097\/HJH.0b013e3283310dc9","article-title":"Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis","volume":"27","author":"Chan","year":"2009","journal-title":"J\u00a0Hypertens"},{"issue":"12","key":"10.1016\/j.adaj.2015.07.020_bib70","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.106.181424","article-title":"Use of nonsteroidal antiinflammatory drugs: an update for clinicians\u2014a scientific statement from the American Heart Association","volume":"115","author":"Antman","year":"2007","journal-title":"Circulation"},{"issue":"9357","key":"10.1016\/j.adaj.2015.07.020_bib71","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(03)12509-3","article-title":"Effect of ibuprofen on cardioprotective effect of aspirin","volume":"361","author":"MacDonald","year":"2003","journal-title":"Lancet"},{"issue":"7427","key":"10.1016\/j.adaj.2015.07.020_bib72","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/bmj.327.7427.1322","article-title":"Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study","volume":"327","author":"Curtis","year":"2003","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.adaj.2015.07.020_bib73","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/archinte.164.8.852","article-title":"Use of aspirin and ibuprofen compared with aspirin alone and the risk of myocardial infarction","volume":"164","author":"Patel","year":"2004","journal-title":"Arch Intern Med"},{"issue":"7472","key":"10.1016\/j.adaj.2015.07.020_bib74","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/bmj.38232.680567.EB","article-title":"The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review","volume":"329","author":"Hooper","year":"2004","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.adaj.2015.07.020_bib75","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/ard.2004.028886","article-title":"EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"64","author":"Zhang","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.adaj.2015.07.020_bib76","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines","volume":"16","author":"Zhang","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"issue":"10","key":"10.1016\/j.adaj.2015.07.020_bib77","first-page":"679","article-title":"Renal effects of low dose aspirin in elderly patients","volume":"8","author":"Segal","year":"2006","journal-title":"Isr Med Assoc J"},{"issue":"6","key":"10.1016\/j.adaj.2015.07.020_bib78","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0002-9343(03)00436-4","article-title":"Early and late effects of low-dose aspirin on renal function in elderly patients","volume":"115","author":"Segal","year":"2003","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.adaj.2015.07.020_bib79","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrneph.2009.234","article-title":"Hospital-acquired acute kidney injury in the elderly","volume":"6","author":"Chronopoulos","year":"2010","journal-title":"Nat Rev Nephrol"},{"issue":"17","key":"10.1016\/j.adaj.2015.07.020_bib80","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.adaj.2015.07.020_bib81","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2369-8-15","article-title":"Analgesics use and ESRD in younger age: a case-control study","volume":"8","author":"van der Woude","year":"2007","journal-title":"BMC Nephrol"},{"issue":"10","key":"10.1016\/j.adaj.2015.07.020_bib82","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00228-014-1734-6","article-title":"Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects","volume":"70","author":"Wehling","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.adaj.2015.07.020_bib83","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/all.12629","article-title":"NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity","volume":"70","author":"Morales","year":"2015","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.adaj.2015.07.020_bib84","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaci.2013.10.057","article-title":"Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: meta-analysis of controlled clinical trials","volume":"134","author":"Morales","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.adaj.2015.07.020_bib85","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4168\/aair.2014.6.2.156","article-title":"Cross-reactivity to acetaminophen and celecoxib according to the type of nonsteroidal anti-inflammatory drug hypersensitivity","volume":"6","author":"Kim","year":"2014","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"10.1016\/j.adaj.2015.07.020_bib86","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0091-6749(89)90174-7","article-title":"Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma","volume":"84","author":"Settipane","year":"1989","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.adaj.2015.07.020_bib87","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/j.1398-9995.2011.02684.x","article-title":"Response to a selective COX-2 inhibitor in patients with urticaria\/angioedema induced by nonsteroidal anti-inflammatory drugs","volume":"66","author":"Dona","year":"2011","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.adaj.2015.07.020_bib88","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/0030-4220(93)90034-2","article-title":"Single dose and multidose analgesic study of ibuprofen and meclofenamate sodium after third molar surgery","volume":"76","author":"Hersh","year":"1993","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"6","key":"10.1016\/j.adaj.2015.07.020_bib89","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3727\/107156994819564429","article-title":"Multidose analgesic study of two\u00a0meclofenamate acid formulations in a postsurgical dental pain model","volume":"1","author":"Cooper","year":"1994","journal-title":"Analgesia"}],"container-title":["The Journal of the American Dental Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002817715008041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002817715008041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T19:30:14Z","timestamp":1692127814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002817715008041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0002817715008041"],"URL":"https:\/\/doi.org\/10.1016\/j.adaj.2015.07.020","relation":{},"ISSN":["0002-8177"],"issn-type":[{"value":"0002-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term use of nonsteroidal anti-inflammatory drugs and adverse effects","name":"articletitle","label":"Article Title"},{"value":"The Journal of the American Dental Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adaj.2015.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Dental Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}